<SEC-DOCUMENT>0001213900-20-004279.txt : 20200728
<SEC-HEADER>0001213900-20-004279.hdr.sgml : 20200728
<ACCEPTANCE-DATETIME>20200219171655
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001213900-20-004279
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20200219

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ADiTx Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001726711
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				823204328
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		11161 ANDERSON STREET
		STREET 2:		SUITE 105-10014
		CITY:			LOMA LINDA
		STATE:			CA
		ZIP:			92354
		BUSINESS PHONE:		909-488-0844

	MAIL ADDRESS:	
		STREET 1:		11161 ANDERSON STREET
		STREET 2:		SUITE 105-10014
		CITY:			LOMA LINDA
		STATE:			CA
		ZIP:			92354
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 70%"><IMG SRC="img_001.jpg" ALT="">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; width: 30%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Sheppard, Mullin, Richter &amp; Hampton LLP</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">30 Rockefeller Plaza</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">New York, New York 10112-0015</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">212.653.8700 main</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">212.653.8701 fax</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">www.sheppardmullin.com</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">February 19, 2020</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>VIA EDGAR</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">U.S. Securities and Exchange Commission</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Division of Corporation Finance</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">100 F Street, NE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Washington, D.C. 20549</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Re:</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">ADiTx Therapeutics, Inc.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Amendment No. 1 to Registration Statement on Form S-1</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Filed February 7, 2020</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">File No. 333-235933</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This letter sets forth
the responses of ADiTx Therapeutics, Inc., a Delaware corporation (the &ldquo;<B>Company</B>&rdquo;), to the comments received
from the Staff (the &ldquo;<B>Staff</B>&rdquo;) of the U.S. Securities and Exchange Commission (the &ldquo;<B>Commission</B>&rdquo;)
concerning its Amendment No. 1 to Registration Statement on Form S-1 (File No. 333-235933) filed with the Commission on February
7, 2020 (the &ldquo;<B>Registration Statement</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">References in the text
of the responses herein to captions and page numbers refer to Amendment No. 2 to the Company&rsquo;s Registration Statement on
Form S-1 (the &ldquo;<B>Amended Registration Statement</B>&rdquo;), which is being filed herewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Registration Statement on Form S-1/A, filed on February 7,
2020</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Use of Proceeds, page 27</U>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1. QUESTION:</B></FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>We note that you entered into bridge loans with principal amounts of $50,000 and $80,000 in January 2020, which are due on the earlier of April 19, 2020 and April 29, 2020, respectively, or ten days after the close of the company&rsquo;s initial public offering. If you will be using the proceeds of this offering to discharge this indebtedness, please revise your disclosure in this section pursuant to Instruction 4 of Item 504 of Regulation S-K.</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RESPONSE:</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has revised its disclosure with respect to the Use of Proceeds section. Please see page 27 of the Amended Registration Statement.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Recent Developments, page 42</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2. QUESTION:</B></FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>We note your entry into a patent and licensing agreement on February 3, 2020. Please revise to disclose the identity of the counter party to the agreement, the royalty term and the agreement&rsquo;s termination provisions.</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RESPONSE:</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has revised its disclosure. Please see page 42 of the Amended Registration Statement.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If you have any questions
relating to any of the foregoing, please contact Richard Friedman of Sheppard, Mullin, Richter&nbsp;&amp; Hampton LLP at (212)
653-8700.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Very truly yours,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%; border-bottom: black 1.5pt solid; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Richard Friedman</FONT></TD>
    <TD STYLE="width: 60%; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Richard Friedman</FONT></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps">Sheppard, Mullin, Richter &amp; Hampton LLP</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>img_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  8 . # 2(  A$! Q$!_\0
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MF!XO^)_A"P_;SU7X/WNLZ;XV7_@GW\8K^R.EW8.IB70O&?@)$UL;N!XE\)Z
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M.#QYXTM_ 7A?]JOX?OXAU2Z:RTE=7LO%WAWP[?ZEC)B3QMX@T"W\*DMV9KI
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M&=:T3P]Y6KZ.#()-?67^QI/F@C=@8U\PA<!E)=MQGZ<:%^W;^S!\3=4U_P
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MP9O$OPIM-8;2O /_  FTFO:-&/'6[X=^$6+^*93H<EO^[D2((Z#R@Z[OPO\
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M88C1]:5 ?#,^@EL#R%\)(2"?G4E0WV!J'_!*W]EC6?@9\#?V?+RQ\?M\/O@
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7-9D&C")8\,=<DX$AP!&2^)/E** /_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
